Introducing our new blood-stage malaria vaccine immunogen based on the essential invasion protein PfCyRPA. By understanding where on PfCyRPA the best antibodies bind, we used structure guided design to generate PfCyRPA-EM, which contains only the epitopes of the best antibodies.
Delighted to share the final version of Richard Zhou's study on how the CD163 scavenger receptor cleans up after toxic haemoglobin spills out from our blood cells. An amazing grabber mechanism!
https://t.co/T4hjaHnedb
Our latest story describes the amazing evolutionary battle between malaria parasite and human. The parasite evolved RIFINs to bind inhibitory KIR receptors and suppress immune cell function while humans have activating KIR receptors to bind these RIFINs to kill parasites!
Looking for a fully-funded D. Phil. / Ph.D. studentship in structural biology and vaccinology? Come to join our team. Fully and generously funded by a donation from the Kyner-Field family with full fees at overseas level. Join us??
https://t.co/KZMGLmTGI3
@nawsad_alam presented our structure-guided design of RH5top, our latest blood stage-malaria vaccine immunogen in talk and poster at the Malaria Gordon conference. The culmination of many studies from the lab and doing well in pre-clinical testing! More soon.
Another job available in our team! We are seeking a project manager to help us to manage our malaria vaccine development projects. See here:
https://t.co/ZIsiBkHokL
We have a position available for a research assistant to join our team to test our rationally designed malaria vaccines. A fun job with a lovely team of people and an important project funded by the Gates Foundation. Come and join us!
https://t.co/m3nZQNw1jH
The capability for producing "mirror life" is out there and poses danger. When some scientists who worked on this became aware, they stopped pursuing it, and co-authored this piece, along with over 30 leading scientists—a @ScienceMagazine policy forum that lays out the risks
https://t.co/ud23zfG3o2
Thanks @TrendsParasitol for highlighting our structure-guided design of PfRH5-based vaccines. In particular, PfRH5.2 which combines truncations from Wright et al (2014) and mutations from Campeotto et al (2017). Good to see it outperforming PfRH5.1!
https://t.co/6ZtSw87mGc
Thanks @TrendsParasitol for highlighting our structure-guided design of PfRH5-based vaccines. In particular, PfRH5.2 which combines truncations from Wright et al (2014) and mutations from Campeotto et al (2017). Good to see it outperforming PfRH5.1!
https://t.co/6ZtSw87mGc
Scotland has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13.
https://t.co/clCeKqILrP
#MeetTheResearcher
Introducing @nawsad_alam from Professor Matt Higgins' lab. As a postdoctoral researcher, Nawsad uses structure-guided approaches to design effective blood-stage #malaria vaccine candidates.
Presenting this work malaria blood stage vaccine design and interacting with other attendees was a great experience. @EMBLEvents#EMBLMalaria#BioMalPar2024
Thrilled to announce AlphaFold 3 which can predict the structures and interactions of nearly all of life’s molecules with state-of-the-art accuracy including proteins, DNA and RNA. Biology is a complex dynamical system so modeling interactions is crucial https://t.co/Gs4GoOB3fD
This immungen elicited a high-quality growth inhibitory response. We also showed that a first dose of this highly focused immunogen, followed by subsequent doses of the broader immunogen, PfRH5, was most effective. Read all about it here:
https://t.co/342QdtiM1s